ThermoGenesis was founded in 1987 and initially focused on the research, development and refinement of product design for its ThermoLine blood plasma freezers and thawers. Between 1996 and 1999 the company completed development of the BioArchive® Platform for processing, cryopreserving and archiving units of blood and blood components. And most recently the company completed development of the CryoSeal® Fibrin Sealant (FS) System and completed its U.S. pre-clinical trials for the CryoSeal FS System. ThermoGenesis is committed to be the leading supplier of innovative products and services that process, store, and administer therapeutic doses of adult stem cells for treatment of disease and injury.